Prof Dr Ronald Sroka 24 Nov

About the Speaker

Ronald Sroka is the head of the Laser-Forschungslabor (LFL) (Laser-Research Laboratory) at LIFE-Centre of University Hospital Munich since 2010. As physicist he received PhD degree at the Medical Faculty of the University Munich in 1992. Since 1986, he was mostly engaged in the research and development of fluorescence diagnosis, Photodynamic Therapy (PDT) and laser surgery in nearly all medical disciplines focusing on the translational technical implementation of several laser applications into the clinics (e.g. Urology: laser lithotripsy, PDT of prostate cancer, BPH vaporization and enucleation; ENT: laser assisted tonsillotomy and nasal applications; phlebology: endoluminal laser ablation of varicose vein; GI: PDT of Barrett cancer). Ronald Sroka gained experience in project management as principal investigator with several national bi- or multilateral projects, as well as interdisciplinary and translational research projects of clinical relevance. Apart from a long publication list, he is the General Secretary of the German Society of Lasermedicine (DGLM e.V.), SPIE-fellow, OPTICA-senior member, organizer, co-organizer and chair of several international and national conferences and finally serves as editor in chief of TBIO, associate editor BOEx and reviewer for several laser medicine- and biophotonic-related journals. Since 2015 he is honoured as Adjunct-Professor of Tongji University Shanghai, China and is part of the Advisory Board of Institute of Photomedicine, Tongji University Shanghai, China.


Based on an introduction to basic principles of laser-tissue interaction an overview about research and development activities as well as its translation into clinical applications will be given. Starting from diagnostics procedures for tissue differentiation treatment modalities from non-thermal light application like photodynamic therapy (e.g. bladder cancer, prostate cancer, brain cancer) to laser-thermal induced processes like coagulation and vaporisation (e.g. treatment of varicosis, hyperplastic turbinates and benign prostate hyperplasia) to laser-induced shockwave processes (e.g. stone fragmentation) will be presented. Furthermore, the potential of point-of-care testing using spectroscopy will be shown.